Shan Wu
Corporate Officer/Principal en VIRIDIAN THERAPEUTICS, INC. .
Perfil
Shan Wu is currently the Chief Business Officer at Viridian Therapeutics, Inc. Prior to this role, she served as the Vice President & Head of Business Development at Magenta Therapeutics, Inc. from 2021 to 2023.
Dr. Wu completed her undergraduate degree at the University of Virginia and holds a doctorate from the Massachusetts Institute of Technology.
Cargos activos de Shan Wu
| Empresas | Cargo | Inicio |
|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Corporate Officer/Principal | 30/10/2023 |
Antiguos cargos conocidos de Shan Wu.
| Empresas | Cargo | Fin |
|---|---|---|
| MAGENTA THERAPEUTICS | Contacto de Relaciones con Inversores | 01/09/2023 |
Formación de Shan Wu.
| Massachusetts Institute of Technology | Doctorate Degree |
| University of Virginia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Shan Wu
